Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue

Bojana Cemerikic, Robert Schabbing, Mahmoud Ahmed

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The in vitro effect of three opioid peptides on hCG release from term trophoblast tissue was investigated. These peptides were prototypic for opioid receptors of the following types: kappa [dynorphin(1-13)], mu (DAMGO) H-Tyr-d-Ala2-Gly-N-Me-Phe-Gly5-ol, and delta (DPDPE) H-Tyr-O-Pen-Gly-Phe-d-Pen-OH[d-Pen2,d-Pen5]enkephalin. All peptides stimulated hCG release and their concentration-response curves were bell shaped. Their order of potency was kappa ⋙ mu > delta. Stimulation of hCG release by any of the peptides was totally reversed by opioid antagonists, indicating that the action of peptides is mediated by placental opioid receptors. In order to confirm the specificity of opioid regulation of hCG release, three nonopioid drugs (cocaine, nicotine, and isoproterenol), with binding proteins and receptors known to be present in trophoblast tissue membranes, were also investigated. Stimulation of hCG release caused by certain concentrations of nonopioid drugs was not reversed by opioid antagonists, demonstrating that their effect is not mediated by opioid receptors. Furthermore, the concentration-response curve of isoproterenol was biphasic, suggesting the presence of a mechanism regulating hCG release that is not mediated by placental β-adrenergic receptors. Data presented in this manuscript indicate that placental opioid receptors mediate one of the mechanisms regulating hCG release from trophoblast tissue and confirm our earlier results using opioid drugs.

Original languageEnglish (US)
Pages (from-to)897-903
Number of pages7
JournalPeptides
Volume13
Issue number5
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Opioid Peptides
Trophoblasts
Chorionic Gonadotropin
Opioid Receptors
Tissue
Peptides
Narcotic Antagonists
Isoproterenol
Opioid Analgesics
glycylphenylalanine
D-Penicillamine (2,5)-Enkephalin
Pharmaceutical Preparations
Ala(2)-MePhe(4)-Gly(5)-enkephalin
kappa Opioid Receptor
Enkephalins
Nicotine
Cocaine
Adrenergic Receptors
Carrier Proteins
Membranes

Keywords

  • Gonadotropin release
  • Opioid peptides
  • Trophoblast tissue

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue. / Cemerikic, Bojana; Schabbing, Robert; Ahmed, Mahmoud.

In: Peptides, Vol. 13, No. 5, 1992, p. 897-903.

Research output: Contribution to journalArticle

@article{a3fe41f4cf704c1c863f2742d9fa0de9,
title = "Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue",
abstract = "The in vitro effect of three opioid peptides on hCG release from term trophoblast tissue was investigated. These peptides were prototypic for opioid receptors of the following types: kappa [dynorphin(1-13)], mu (DAMGO) H-Tyr-d-Ala2-Gly-N-Me-Phe-Gly5-ol, and delta (DPDPE) H-Tyr-O-Pen-Gly-Phe-d-Pen-OH[d-Pen2,d-Pen5]enkephalin. All peptides stimulated hCG release and their concentration-response curves were bell shaped. Their order of potency was kappa ⋙ mu > delta. Stimulation of hCG release by any of the peptides was totally reversed by opioid antagonists, indicating that the action of peptides is mediated by placental opioid receptors. In order to confirm the specificity of opioid regulation of hCG release, three nonopioid drugs (cocaine, nicotine, and isoproterenol), with binding proteins and receptors known to be present in trophoblast tissue membranes, were also investigated. Stimulation of hCG release caused by certain concentrations of nonopioid drugs was not reversed by opioid antagonists, demonstrating that their effect is not mediated by opioid receptors. Furthermore, the concentration-response curve of isoproterenol was biphasic, suggesting the presence of a mechanism regulating hCG release that is not mediated by placental β-adrenergic receptors. Data presented in this manuscript indicate that placental opioid receptors mediate one of the mechanisms regulating hCG release from trophoblast tissue and confirm our earlier results using opioid drugs.",
keywords = "Gonadotropin release, Opioid peptides, Trophoblast tissue",
author = "Bojana Cemerikic and Robert Schabbing and Mahmoud Ahmed",
year = "1992",
doi = "10.1016/0196-9781(92)90047-7",
language = "English (US)",
volume = "13",
pages = "897--903",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue

AU - Cemerikic, Bojana

AU - Schabbing, Robert

AU - Ahmed, Mahmoud

PY - 1992

Y1 - 1992

N2 - The in vitro effect of three opioid peptides on hCG release from term trophoblast tissue was investigated. These peptides were prototypic for opioid receptors of the following types: kappa [dynorphin(1-13)], mu (DAMGO) H-Tyr-d-Ala2-Gly-N-Me-Phe-Gly5-ol, and delta (DPDPE) H-Tyr-O-Pen-Gly-Phe-d-Pen-OH[d-Pen2,d-Pen5]enkephalin. All peptides stimulated hCG release and their concentration-response curves were bell shaped. Their order of potency was kappa ⋙ mu > delta. Stimulation of hCG release by any of the peptides was totally reversed by opioid antagonists, indicating that the action of peptides is mediated by placental opioid receptors. In order to confirm the specificity of opioid regulation of hCG release, three nonopioid drugs (cocaine, nicotine, and isoproterenol), with binding proteins and receptors known to be present in trophoblast tissue membranes, were also investigated. Stimulation of hCG release caused by certain concentrations of nonopioid drugs was not reversed by opioid antagonists, demonstrating that their effect is not mediated by opioid receptors. Furthermore, the concentration-response curve of isoproterenol was biphasic, suggesting the presence of a mechanism regulating hCG release that is not mediated by placental β-adrenergic receptors. Data presented in this manuscript indicate that placental opioid receptors mediate one of the mechanisms regulating hCG release from trophoblast tissue and confirm our earlier results using opioid drugs.

AB - The in vitro effect of three opioid peptides on hCG release from term trophoblast tissue was investigated. These peptides were prototypic for opioid receptors of the following types: kappa [dynorphin(1-13)], mu (DAMGO) H-Tyr-d-Ala2-Gly-N-Me-Phe-Gly5-ol, and delta (DPDPE) H-Tyr-O-Pen-Gly-Phe-d-Pen-OH[d-Pen2,d-Pen5]enkephalin. All peptides stimulated hCG release and their concentration-response curves were bell shaped. Their order of potency was kappa ⋙ mu > delta. Stimulation of hCG release by any of the peptides was totally reversed by opioid antagonists, indicating that the action of peptides is mediated by placental opioid receptors. In order to confirm the specificity of opioid regulation of hCG release, three nonopioid drugs (cocaine, nicotine, and isoproterenol), with binding proteins and receptors known to be present in trophoblast tissue membranes, were also investigated. Stimulation of hCG release caused by certain concentrations of nonopioid drugs was not reversed by opioid antagonists, demonstrating that their effect is not mediated by opioid receptors. Furthermore, the concentration-response curve of isoproterenol was biphasic, suggesting the presence of a mechanism regulating hCG release that is not mediated by placental β-adrenergic receptors. Data presented in this manuscript indicate that placental opioid receptors mediate one of the mechanisms regulating hCG release from trophoblast tissue and confirm our earlier results using opioid drugs.

KW - Gonadotropin release

KW - Opioid peptides

KW - Trophoblast tissue

UR - http://www.scopus.com/inward/record.url?scp=0026469720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026469720&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(92)90047-7

DO - 10.1016/0196-9781(92)90047-7

M3 - Article

VL - 13

SP - 897

EP - 903

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 5

ER -